|
  
- 积分
- 97
- 威望
- 97
- 包包
- 3142
|
本帖最后由 bobo 于 2009-6-28 08:34 编辑 ; u8 E6 R5 t7 b. d
& Y$ p3 [. G$ }8 y J: u4 G
表观遗传学与干细胞——2009年亚洲生物高峰论坛录制(音频mp3)
$ e* ]& @+ X: n& c* |
O$ B- u- K5 t' T2 D3 m. w- W! O; n' @
$ J$ w! C1 ^4 D l/ Q- `+ P- L- n
回复为ppt
- p1 g3 R/ E' I F0 U摘要：) ^5 \! q4 N) }4 y: ~! \/ `) J
. M7 v! |5 ^! i, U' K; {$ V+ Y
Hongkui Deng5 m5 \. {/ r* v/ ], R; S/ d; N$ ? V
! S( Q7 \ K7 ?7 t5 H
Laboratory of Stem Cell and Generative Biology, College of Life Sciences, Peking University, Beijing 100871, China.4 w# K, V1 \5 ], F. o5 q' z/ o' g2 G
! A( Z0 v, d0 ?, s3 X6 j8 X& m; ^; w
Human pluripotent stem cells represent a potentially unlimited source of functional pancreatic endocrine lineage cells. We established a new highly efficient approach to induce human embryonic stem （ES） cells and induced pluripotent stem （iPS） cells to differentiate into mature insulin-producing cells in a chemical-defined culture system. The differentiated cells obtained by this approach comprised nearly 25% insulin-positive cells as assayed by flow cytometry analysis, which released insulin/C-peptide in response to glucose stimuli in a manner comparable to that of adult human islets. Most of these insulin-producing cells co-expressed mature beta cell-specific markers such as NKX6-1 and PDX1, indicating a similar gene expression pattern to adult islet beta cells in vivo. This work provides a new model to study the mechanism of human pancreatic specialization and maturation in vitro, and enhances the possibility of utilizing patient-specific iPS cells for the treatment of diabetes
/ e1 A# l/ c; U2 x S1 l9 I+ f+ h+ y5 ~
回复为ppt
8 q# B7 C, @6 j* G+ {$ l5 N! o" i
4 U3 t, x) H0 |, O) V4 M+ R1 ]- T+ N7 y5 F6 i& J
/ e5 X/ d8 X5 t/ H1 q4 {! X ^
f# { W0 J" K0 _5 e+ | |
附件: 你需要登录才可以下载或查看附件。没有帐号？注册
|
发表于 2009-6-28 08:19
发表于 2009-8-7 16:10
